DK1155014T3 - Hidtil ukendte benzimidazolforbindelser til anvendelse som aktive, terapeutiske stoffer, fremgangsmåde til fremstilling af disse forbindelser og farmaceutiske sammensætninger omfattende dem - Google Patents
Hidtil ukendte benzimidazolforbindelser til anvendelse som aktive, terapeutiske stoffer, fremgangsmåde til fremstilling af disse forbindelser og farmaceutiske sammensætninger omfattende demInfo
- Publication number
- DK1155014T3 DK1155014T3 DK00902282T DK00902282T DK1155014T3 DK 1155014 T3 DK1155014 T3 DK 1155014T3 DK 00902282 T DK00902282 T DK 00902282T DK 00902282 T DK00902282 T DK 00902282T DK 1155014 T3 DK1155014 T3 DK 1155014T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- compounds
- substituted
- aryl
- processes
- Prior art date
Links
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000003107 substituted aryl group Chemical group 0.000 abstract 5
- 102000002265 Human Growth Hormone Human genes 0.000 abstract 4
- 108010000521 Human Growth Hormone Proteins 0.000 abstract 4
- 239000000854 Human Growth Hormone Substances 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 4
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 3
- 101100079984 Caenorhabditis elegans nhr-9 gene Proteins 0.000 abstract 2
- 125000002877 alkyl aryl group Chemical group 0.000 abstract 2
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 abstract 2
- 101100134927 Gallus gallus COR8 gene Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 101001043818 Mus musculus Interleukin-31 receptor subunit alpha Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9900211A SE9900211D0 (sv) | 1999-01-25 | 1999-01-25 | New compounds |
| PCT/SE2000/000144 WO2000043387A1 (en) | 1999-01-25 | 2000-01-24 | New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1155014T3 true DK1155014T3 (da) | 2003-09-29 |
Family
ID=20414207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00902282T DK1155014T3 (da) | 1999-01-25 | 2000-01-24 | Hidtil ukendte benzimidazolforbindelser til anvendelse som aktive, terapeutiske stoffer, fremgangsmåde til fremstilling af disse forbindelser og farmaceutiske sammensætninger omfattende dem |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1155014B1 (da) |
| JP (1) | JP2002535325A (da) |
| AT (1) | ATE242237T1 (da) |
| AU (1) | AU760346B2 (da) |
| CA (1) | CA2359107A1 (da) |
| DE (1) | DE60003158T2 (da) |
| DK (1) | DK1155014T3 (da) |
| ES (1) | ES2202045T3 (da) |
| NZ (1) | NZ512597A (da) |
| PT (1) | PT1155014E (da) |
| SE (1) | SE9900211D0 (da) |
| WO (1) | WO2000043387A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102361857B (zh) * | 2008-09-26 | 2015-09-16 | 默沙东公司 | 可用作抗糖尿病剂的环状苯并咪唑衍生物 |
| GB0908394D0 (en) | 2009-05-15 | 2009-06-24 | Univ Leuven Kath | Novel viral replication inhibitors |
| GB0913636D0 (en) | 2009-08-05 | 2009-09-16 | Univ Leuven Kath | Novel viral replication inhibitors |
| JP2013542243A (ja) | 2010-11-15 | 2013-11-21 | カトリーケ ウニヴェルシテイト ルーヴェン | 新規な抗ウイルス性化合物 |
-
1999
- 1999-01-25 SE SE9900211A patent/SE9900211D0/xx unknown
-
2000
- 2000-01-24 WO PCT/SE2000/000144 patent/WO2000043387A1/en not_active Ceased
- 2000-01-24 DK DK00902282T patent/DK1155014T3/da active
- 2000-01-24 EP EP00902282A patent/EP1155014B1/en not_active Expired - Lifetime
- 2000-01-24 AU AU23406/00A patent/AU760346B2/en not_active Ceased
- 2000-01-24 DE DE60003158T patent/DE60003158T2/de not_active Expired - Fee Related
- 2000-01-24 NZ NZ512597A patent/NZ512597A/en unknown
- 2000-01-24 JP JP2000594803A patent/JP2002535325A/ja not_active Withdrawn
- 2000-01-24 AT AT00902282T patent/ATE242237T1/de not_active IP Right Cessation
- 2000-01-24 ES ES00902282T patent/ES2202045T3/es not_active Expired - Lifetime
- 2000-01-24 PT PT00902282T patent/PT1155014E/pt unknown
- 2000-01-24 CA CA002359107A patent/CA2359107A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ512597A (en) | 2003-12-19 |
| PT1155014E (pt) | 2003-10-31 |
| ATE242237T1 (de) | 2003-06-15 |
| EP1155014A1 (en) | 2001-11-21 |
| CA2359107A1 (en) | 2000-07-27 |
| WO2000043387A1 (en) | 2000-07-27 |
| JP2002535325A (ja) | 2002-10-22 |
| SE9900211D0 (sv) | 1999-01-25 |
| DE60003158T2 (de) | 2003-12-04 |
| EP1155014B1 (en) | 2003-06-04 |
| AU2340600A (en) | 2000-08-07 |
| DE60003158D1 (de) | 2003-07-10 |
| ES2202045T3 (es) | 2004-04-01 |
| AU760346B2 (en) | 2003-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200201874T2 (tr) | Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler. | |
| EA200200208A1 (ru) | Синергитическая композиция | |
| AR027548A1 (es) | Derivados de amino pirazol utiles para el tratamiento de la obesidad y otros desordenes | |
| CY1111698T1 (el) | Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης | |
| ATE302775T1 (de) | Carbolinderivate | |
| DK1487829T3 (da) | Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte | |
| PL372319A1 (en) | Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same | |
| BR0207872A (pt) | Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração | |
| UY26439A1 (es) | Nueva composición y uso | |
| CY1112376T1 (el) | Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2 | |
| ATE346067T1 (de) | Carbolinderivate | |
| ATE300543T1 (de) | Kondensierte pyrazindionderivate als pde5 inhibitore | |
| AR039190A1 (es) | Derivados de benzofurano, composicion farmaceutica y medicamento que comprende el compuesto | |
| DE60301339D1 (de) | Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen | |
| DK1189900T3 (da) | Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler | |
| AR038143A1 (es) | Agonistas del receptor 2 del factor liberador de la corticotropina | |
| SE0301699D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| ATE333457T1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
| NO20014855L (no) | N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister | |
| DK1155014T3 (da) | Hidtil ukendte benzimidazolforbindelser til anvendelse som aktive, terapeutiske stoffer, fremgangsmåde til fremstilling af disse forbindelser og farmaceutiske sammensætninger omfattende dem | |
| AR023111A1 (es) | Derivados de sulfonamida utiles como antagonistas del receptor 5-ht7, un procedimiento para su preparacion y composicion farmaceutica que los comprenden | |
| DK1412332T3 (da) | Quinolinderivater og anvendelse deraf som antitumormidler | |
| ATE293111T1 (de) | Kondensierte pyrazindionderivate als pde inhibitoren | |
| ATE274515T1 (de) | Pyrazolopyridinderivate | |
| ATE329916T1 (de) | Azaindolylpiperidinderivate als antihistaminika und antiallergika |